140 related articles for article (PubMed ID: 15115874)
1. Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma.
Baldi A; Santini D; Vasaturo F; Santini M; Vicidomini G; Di Marino MP; Esposito V; Groeger AM; Liuzzi G; Vincenzi B; Tonini G; Piccoli M; Baldi F; Scarpa S
Thorax; 2004 May; 59(5):428-33. PubMed ID: 15115874
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1.
Zahner G; Wolf G; Ayoub M; Reinking R; Panzer U; Shankland SJ; Stahl RA
J Biol Chem; 2002 Mar; 277(12):9763-71. PubMed ID: 11756433
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 expression predicts survival in malignant pleural mesothelioma.
O'Kane SL; Cawkwell L; Campbell A; Lind MJ
Eur J Cancer; 2005 Jul; 41(11):1645-8. PubMed ID: 15964184
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
6. Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival.
Baldi A; Groeger AM; Esposito V; Cassandro R; Tonini G; Battista T; Di Marino MP; Vincenzi B; Santini M; Angelini A; Rossiello R; Baldi F; Paggi MG
Thorax; 2002 Apr; 57(4):353-6. PubMed ID: 11923556
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
[TBL] [Abstract][Full Text] [Related]
8. Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance.
Haitel A; Wiener HG; Neudert B; Marberger M; Susani M
Urology; 2001 Sep; 58(3):477-81. PubMed ID: 11549509
[TBL] [Abstract][Full Text] [Related]
9. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.
Kirla RM; Haapasalo HK; Kalimo H; Salminen EK
Cancer; 2003 Feb; 97(3):644-8. PubMed ID: 12548606
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S
Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464
[TBL] [Abstract][Full Text] [Related]
11. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
12. Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells.
Lee HY; Suh YA; Kosmeder JW; Pezzuto JM; Hong WK; Kurie JM
Clin Cancer Res; 2004 Feb; 10(3):1074-9. PubMed ID: 14871987
[TBL] [Abstract][Full Text] [Related]
13. p27(kip1) immunoreactivity correlates with long-term survival in pleural malignant mesothelioma.
Bongiovanni M; Cassoni P; De Giuli P; Viberti L; Cappia S; Ivaldi C; Chiusa L; Bussolati G
Cancer; 2001 Sep; 92(5):1245-50. PubMed ID: 11571739
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of cell adhesion molecules, cell cycle regulatory proteins, mismatch repair genes, cyclooxygenase-2, and DPC4 in carcinomas arising in inflammatory bowel disease and sporadic colon cancer.
Hill KA; Wang KL; Stryker SJ; Gupta R; Weinrach DM; Rao MS
Oncol Rep; 2004 May; 11(5):951-6. PubMed ID: 15069531
[TBL] [Abstract][Full Text] [Related]
15. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
16. p21Waf1/Cip1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma, but not p27Kip1, p53, or Rb.
Nita ME; Nagawa H; Tominaga O; Tsuno N; Hatano K; Kitayama J; Tsuruo T; Domene CE; Muto T
Ann Surg Oncol; 1999; 6(5):481-8. PubMed ID: 10458687
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of p53, p21, and p27 expressions in rectal carcinoma.
Lebe B; Sarioğlu S; Sökmen S; Ellidokuz H; Füzün M; Küpelioğlu A
Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):38-44. PubMed ID: 15722792
[TBL] [Abstract][Full Text] [Related]
18. Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s).
Narayanan BA; Condon MS; Bosland MC; Narayanan NK; Reddy BS
Clin Cancer Res; 2003 Aug; 9(9):3503-13. PubMed ID: 12960143
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical MIB-1 and p27kip1 as prognostic factors in pleural mesothelioma.
Leonardo E; Zanconati F; Bonifacio D; Bonito LD
Pathol Res Pract; 2001; 197(4):253-6. PubMed ID: 11358011
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer.
Korkmaz H; Du W; Yoo GH; Enamorado II; Lin HS; Adsay V; Kewson D; Ensley JF; Shibuya TY; Jacobs JR; Kim H
Am J Otolaryngol; 2005; 26(2):77-82. PubMed ID: 15742257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
